# Tocotrienol Cholesterol Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/tocotrienol-cholesterol-meta-analysis-evidence-review
Category: evidence-review
Summary: Tocotrienol Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are s
Last reviewed: 2026-08-10
Reviewed by: Migaku Evidence Review
# Tocotrienol Cholesterol Meta-analysis: What the Evidence Says

## Quick Answer

Tocotrienol Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy of Vitamin E Supplementation During Pregnancy on the Vitamin E Nutritional Status of the Mother–Child Dyad: A Systematic Review and Meta‐Analysis of Randomized Controlled Trial | systematic review | 1 | 2026-03-22 | 10.1002/fsn3.71677 |
| Effect of tocotrienol-rich fraction (TRF) on lipid profile in hyperlipidemic experimental animal model: a systematic review and meta-analysis | systematic review | 1 | 2025-09-30 | 10.1038/s41598-025-11160-1 |

## What The Sources Report

- Nutritional demands increase during this period, but populations with limited access to vitamin E-rich foods, such as oils, nuts, and seeds, are at risk of deficiency (Rebouças et al. ; Busso et al. ). [Carneiro Byanca Rodrigues (2026); evidence level 1]
- Recent studies suggest that low vitamin E levels, defined as serum concentrations below 12 μmol/L (Péter et al. ), increase maternal oxidative stress, thereby raising the risk of complications such as preeclampsia and placental abruption (Debier and Larondelle ). [Carneiro Byanca Rodrigues (2026); evidence level 1]
- Hyperlipidemia is defined by increased lipid levels in the body, which can result from various genetic or acquired conditions. [Abdah Hazirah Watikah (2025); evidence level 1]
- In adults, hyperlipidemia is recognized as a significant risk factor for the development of cardiovascular disease (CVD). [Abdah Hazirah Watikah (2025); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For tocotrienol cholesterol meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Carneiro Byanca Rodrigues (2026). Efficacy of Vitamin E Supplementation During Pregnancy on the Vitamin E Nutritional Status of the Mother–Child Dyad: A Systematic Review and Meta‐Analysis of Randomized Controlled Trial. DOI: 10.1002/fsn3.71677. PMCID: PMC13093448. PMID: 42016265. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13093448/
- Abdah Hazirah Watikah (2025). Effect of tocotrienol-rich fraction (TRF) on lipid profile in hyperlipidemic experimental animal model: a systematic review and meta-analysis. DOI: 10.1038/s41598-025-11160-1. PMCID: PMC12485053. PMID: 41028068. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12485053/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.